Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Preliminary ...
Fazenda Mineral Reserves increased 142% to 763 thousand ounces ("koz") of contained gold, extending the Fazenda mine life to 2033 at the current throughput rate of 3,400 tonnes per day. This increase ...